Sinberger, L.A.; Keren-Khadmy, N.; Goldberg, A.; Peretz-Yablonski, T.; Sonnenblick, A.; Salmon-Divon, M.
Revealing the Angiogenic Signature of FH-Deficient Breast Cancer: Genomic Profiling and Clinical Implications. Cancers 2025, 17, 2942.
https://doi.org/10.3390/cancers17182942
AMA Style
Sinberger LA, Keren-Khadmy N, Goldberg A, Peretz-Yablonski T, Sonnenblick A, Salmon-Divon M.
Revealing the Angiogenic Signature of FH-Deficient Breast Cancer: Genomic Profiling and Clinical Implications. Cancers. 2025; 17(18):2942.
https://doi.org/10.3390/cancers17182942
Chicago/Turabian Style
Sinberger, Liat Anabel, Noa Keren-Khadmy, Assaf Goldberg, Tamar Peretz-Yablonski, Amir Sonnenblick, and Mali Salmon-Divon.
2025. "Revealing the Angiogenic Signature of FH-Deficient Breast Cancer: Genomic Profiling and Clinical Implications" Cancers 17, no. 18: 2942.
https://doi.org/10.3390/cancers17182942
APA Style
Sinberger, L. A., Keren-Khadmy, N., Goldberg, A., Peretz-Yablonski, T., Sonnenblick, A., & Salmon-Divon, M.
(2025). Revealing the Angiogenic Signature of FH-Deficient Breast Cancer: Genomic Profiling and Clinical Implications. Cancers, 17(18), 2942.
https://doi.org/10.3390/cancers17182942